$ARMK

Aramark Boosts FY26 Organic Revenue Growth - Update

Aramark (ARMK) reported third-quarter results and reaffirmed its FY2026 adjusted EPS growth outlook of 20% to 25%. It raised its FY2026 organic revenue growth forecast to 9% to 10% from the prior high-end 7% to 9%. The board approved a $0.12 quarterly dividend payable Sept. 9, 2026. ARMK was about $55 premarket.

Original reporting
Published Aug 11, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 12:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aramark Boosts FY26 Organic Revenue Growth - Update — source image
Decision brief

The 30-second read

$ARMKBullishMed
01

Why it matters

Traders can update forward revenue expectations toward the new 9% to 10% organic growth range while keeping EPS growth expectations anchored to the reaffirmed 20% to 25% band.

02

Market read

A guidance update with specific organic revenue growth uplift is a direct input for near-term estimate revisions and valuation.

03

What to watch

The article does not quantify margin, cash flow, or segment drivers behind the organic growth change, limiting conviction on how durable the improvement is.

Relevance 7/10Novelty 6/10Timing: pre-market today, after Q3 results and FY26 guidance update

Background

The company reported Q3 results and issued an FY26 outlook update, including organic revenue growth and adjusted EPS growth guidance.

Company-level read

Ticker impact

$ARMKBullishMedium confidence
Context

Aramark reaffirmed FY26 adjusted EPS growth of 20% to 25% while raising organic revenue growth to 9% to 10%.

Expected impact

Likely modest positive bias for the stock as traders price in stronger top-line momentum versus the prior 7% to 9% range.

Evidence & confidence

The article provides specific, time-relevant guidance numbers (organic revenue raised) plus reaffirmed EPS growth, which can drive estimate revisions and sentiment.

Market effects

Improved organic growth outlook can be read across to managed services and contract food services demand expectations.

No explicit regional demand signal provided.

No explicit global macro or international segment detail provided.

Counterpoint

Raised organic revenue growth may not translate to upside if margins or costs are pressured, since adjusted EPS growth guidance was only reaffirmed.

Key entities

  • Aramark

    Reaffirmed FY26 adjusted EPS growth (20% to 25%) and raised organic revenue growth outlook (9% to 10%).

  • Aramark Board of Directors

    Approved a quarterly dividend of $0.12 per share, payable September 9, 2026.

Related articles

$ARMKMedAI 8/10

Why Aramark (ARMK) Stock Is Up Today

Aramark (NYSE: ARMK) shares rose about 9.8% after the company reported better-than-expected Q3 2026 results. Revenue was $5.06B, up 9.3% year over year, and adjusted EPS was $0.52 above consensus. Free cash flow turned positive at $8.69M versus a $33.55M loss a year earlier, supporting investor sentiment.

$ARMKHighAI 9/10

Why is Aramark stock surging today?

Aramark (ARMK) shares rose about 8.3% after the company reported fiscal Q3 2026 adjusted EPS of $0.52 vs $0.48 consensus and revenue of $5.1B vs $4.92B forecast. Organic revenue grew 9% and adjusted operating income rose to $261M. Aramark raised FY26 organic revenue guidance to 9–10% and reaffirmed adjusted EPS growth of 20–25%.

$ARMKMed

Aramark (NYSE:ARMK) Surprises With Q2 CY2026 Sales

Aramark (NYSE:ARMK) reported Q2 CY2026 revenue of $5.06 billion, up 9.3% year over year and 2.4% above Wall Street estimates, according to the company. Non-GAAP adjusted EPS was $0.52, up from $0.40 a year earlier, beating consensus by 7.2%. Analysts expect full-year EPS to rise to $2.57 from $2.09.

$ARMKHigh

Aramark (ARMK): Results of Operations and Financial Condition

Aramark (ARMK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991armkq3fy2026.htm EX-99.1 Document For Immediate Release Inquiries: Felise Glantz Kissell (215) 409-7287 Kissell-Felise@aramark.com Gene Cleary (215) 409-7945 Cleary-Gene@aramark.com Aramark Reports Third Quarter Earnings YEAR-OVER-YEAR SUMMARY Note: As previously d

$ARMKMedAI 8/10

Aramark (ARMK) – Investment Analysts’ Weekly Ratings Updates

Aramark (NYSE: ARMK) saw multiple brokerages update ratings and price targets from mid-March to mid-May 2026. Bank of America raised its target to $59 (buy); RBC to $55 (outperform); Morgan Stanley to $50 (equal weight); UBS to $56 (buy); JPMorgan to $55 (overweight). Several others reaffirmed “buy” ratings. Aramark also declared a $0.12 quarterly dividend (ex-date May 20), $0.48 annualized, ~0.9% yield.